tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Protagonist Therapeutics price target raised to $81 from $68 at JPMorgan
The FlyProtagonist Therapeutics price target raised to $81 from $68 at JPMorgan
2d ago
PTGX
Protagonist Therapeutics price target raised to $88 from $72 at Barclays
PremiumThe Fly
Protagonist Therapeutics price target raised to $88 from $72 at Barclays
3d ago
PTGX
Protagonist Therapeutics price target raised to $102 from $69 at Citizens JMP
PremiumThe Fly
Protagonist Therapeutics price target raised to $102 from $69 at Citizens JMP
3d ago
PTGX
Protagonist Therapeutics price target raised to $91 from $74 at Clear Street
PremiumThe Fly
Protagonist Therapeutics price target raised to $91 from $74 at Clear Street
3d ago
PTGX
Protagonist Therapeutics Advances Pipeline Amid Financial Loss
PremiumCompany Announcements
Protagonist Therapeutics Advances Pipeline Amid Financial Loss
3d ago
PTGX
Promising Developments and Strategic Progress at Protagonist Therapeutics Drive Buy Rating
PremiumRatingsPromising Developments and Strategic Progress at Protagonist Therapeutics Drive Buy Rating
3d ago
PTGX
Protagonist Therapeutics reports Q3 EPS (62c), consensus (64c)
Premium
The Fly
Protagonist Therapeutics reports Q3 EPS (62c), consensus (64c)
3d ago
PTGX
PTGX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PTGX Earnings this Week: How Will it Perform?
7d ago
PTGX
Protagonist Therapeutics price target raised to $88 from $76 at Truist
PremiumThe Fly
Protagonist Therapeutics price target raised to $88 from $76 at Truist
12d ago
PTGX
Protagonist Therapeutics: Promising Prospects and Increased Price Target Amidst Positive Study Data and Strategic Partnerships
PremiumRatings
Protagonist Therapeutics: Promising Prospects and Increased Price Target Amidst Positive Study Data and Strategic Partnerships
13d ago
PTGX
Protagonist Therapeutics: Promising Drug Development and Strong Clinical Progress Justify Buy Rating
PremiumRatings
Protagonist Therapeutics: Promising Drug Development and Strong Clinical Progress Justify Buy Rating
13d ago
PTGX
Promising Potential of Protagonist Therapeutics’ Icotrokinra Drives Buy Rating Amid Strategic Interest from Johnson & Johnson
PremiumRatings
Promising Potential of Protagonist Therapeutics’ Icotrokinra Drives Buy Rating Amid Strategic Interest from Johnson & Johnson
13d ago
PTGX
Clear Street sees ‘unmatched commercial promise’ for Protagonist’s icotrokinra
PremiumThe FlyClear Street sees ‘unmatched commercial promise’ for Protagonist’s icotrokinra
13d ago
JNJ
PTGX
Protagonist Therapeutics announces icotrokinra data in UC, plaque PsO
Premium
The Fly
Protagonist Therapeutics announces icotrokinra data in UC, plaque PsO
14d ago
PTGX
Protagonist Therapeutics price target raised to $96 from $72 at Citi
Premium
The Fly
Protagonist Therapeutics price target raised to $96 from $72 at Citi
24d ago
PTGX
Protagonist Therapeutics price target raised to $112 from $72 at BMO Capital
PremiumThe Fly
Protagonist Therapeutics price target raised to $112 from $72 at BMO Capital
28d ago
JNJ
PTGX
Protagonist Therapeutics rises 34.1%
PremiumThe Fly
Protagonist Therapeutics rises 34.1%
1M ago
PTGX
Midday Fly By: Trump threatens China tariffs, Kalshi valued at $5B
PremiumThe Fly
Midday Fly By: Trump threatens China tariffs, Kalshi valued at $5B
1M ago
MS
VG
Protagonist Therapeutics resumes, up 28% after report of J&J takeover talks
PremiumThe Fly
Protagonist Therapeutics resumes, up 28% after report of J&J takeover talks
1M ago
JNJ
PTGX
Protagonist Therapeutics trading resumes
PremiumThe FlyProtagonist Therapeutics trading resumes
1M ago
PTGX
J&J in talks to buy Protagonist Therapeutics, WSJ reports
Premium
The Fly
J&J in talks to buy Protagonist Therapeutics, WSJ reports
1M ago
JNJ
PTGX
Protagonist Therapeutics jumps 9%, halted after WSJ report on J&J takeover talks
Premium
The Fly
Protagonist Therapeutics jumps 9%, halted after WSJ report on J&J takeover talks
1M ago
JNJ
PTGX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >